Development of a sandwich ELISA with potential for selective quantification of human lactoferrin protein nitrated through disease or environmental exposure

被引:8
|
作者
Alhalwani, Amani Y. [1 ]
Repine, John E. [2 ]
Knowles, Michelle K. [1 ]
Huffman, J. Alex [1 ]
机构
[1] Univ Denver, Dept Chem & Biochem, 2190 E Iliff Ave, Denver, CO 80208 USA
[2] Univ Colorado, Sch Med, Webb Waring Ctr, 13001 E 17th Pl, Aurora, CO 80045 USA
关键词
Protein nitration; Nitrotyrosine; Ocular disease; Atmospheric pollution; Peroxynitrite; Tetranitromethane; TYROSINE NITRATION; OXIDATIVE DAMAGE; TETRANITROMETHANE; RESIDUES; REAGENT; 3-NITROTYROSINE; NITROTYROSINE; FLUORESCENCE;
D O I
10.1007/s00216-017-0779-7
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Lactoferrin (LF) is an important multifunctional protein that comprises a large fraction of the protein mass in certain human fluids and tissues, and its concentration is often used to assess health and disease. LF can be nitrated by multiple routes, leading to changes in protein structure, and nitrated proteins can negatively impact physiological health via nitrosative stress. Despite an awareness of the detrimental effects of nitrated proteins and the importance of LF within the body, cost-effective methods for detecting and quantifying nitrated lactoferrin (NLF) are lacking. We developed a procedure to selectively quantify NLF using sandwich enzyme-linked immunosorbent assay (ELISA), utilizing a polyclonal anti-LF capture antibody paired with a monoclonal anti-nitrotyrosine detector antibody. The assay was applied to quantify NLF in samples of pure LF nitrated via two separate reactions at molar ratios of excess nitrating agent to the total number of tyrosine residues between 10/1 and 100/1. Tetranitromethane (TNM) was used as a laboratory surrogate for an environmental pathway selective for production of 3-nitrotyrosine, and sodium peroxynitrite (ONOO-) was used as a surrogate for an endogenous nitration pathway. UV-vis spectroscopy (increased absorbance at 350 nm) and fluorescence spectroscopy (emission decreased by > 96%) for each reaction indicate the production of NLF. A lower limit of NLF detection using the ELISA method introduced here was calculated to be 0.065 mu g mL(-1), which will enable the detection of human-physiologically relevant concentrations of NLF. Our approach provides a relatively inexpensive and practical way to assess NLF in a variety of systems.
引用
收藏
页码:1389 / 1396
页数:8
相关论文
共 25 条
  • [21] Epitope of dengue virus E protein detect human antibodies associated with mild disease: a potential peptide for vaccine development
    Sanchez-Burgos, Gilma
    Herrera-Najera, Carla
    Cedillo-Rivera, Roberto
    Dumonteil, Eric
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2020, 24 (01): : 85 - 88
  • [22] Quantification of Mutant Huntingtin Protein (mHTT) in Human Cerebrospinal Fluid to Support Clinical Development of mHTT-Targeting Therapies in Huntington's Disease
    Schutz, Katharina
    Buehler, Alessandra
    Schick, Eginhard
    Young, Marianne Manchester
    Boak, Lauren
    Schobel, Scott A.
    Hawellek, David J.
    NEUROTHERAPEUTICS, 2020, 17 (SUPPL 1) : 23 - 24
  • [23] A NEW MONOCLONAL-ANTIBODY (5D3-F7) WHICH RECOGNIZES HUMAN MONOCYTE-CHEMOTACTIC PROTEIN-1 BUT NOT RELATED CHEMOKINES - DEVELOPMENT OF A SANDWICH ELISA AND IN-SITU DETECTION OF PRODUCING CELLS
    PERI, G
    MILANESE, C
    MATTEUCCI, C
    RUCO, L
    ZHOU, D
    SOZZANI, S
    COLETTA, I
    MANTOVANI, A
    JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 174 (1-2) : 249 - 257
  • [24] The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease
    Avolio, Elisa
    Carrabba, Michele
    Milligan, Rachel
    Williamson, Maia Kavanagh
    Beltrami, Antonio P.
    Gupta, Kapil
    Elvers, Karen T.
    Gamez, Monica
    Foster, Rebecca R.
    Gillespie, Kathleen
    Hamilton, Fergus
    Arnold, David
    Berger, Imre
    Davidson, Andrew D.
    Hill, Darryl
    Caputo, Massimo
    Madeddu, Paolo
    CLINICAL SCIENCE, 2021, 135 (24) : 2668 - 2689